Salicylamide

• Description:

  Salicylamide is an inhibitor of microsomal UDP-glucuronosyltransferase. Salicylamide is an analgesic and anti-pyretic agent.

• Product Name Alternative:

  2-Hydroxybenzamide

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H315, H319, H335

• Target:

  UGT

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/Salicylamide.html

• Purity:

  99.95

• Solubility:

  DMSO : 100 mg/mL (ultrasonic) |H2O : 0.1 mg/mL (ultrasonic)

• Smiles:

  O=C(N)C1=CC=CC=C1O

• Molecular Formula:

  C7H7NO2

• Molecular Weight:

  137.14

• Precautions:

  H302, H315, H319, H335

• References & Citations:

  [1]Kushkevych I, et al. Activity of selected salicylamides against intestinal sulfate-reducing bacteria. Neuro Endocrinol Lett. 2015;36 Suppl 1:106-13.|[2]Halstead PK, et al. Effect of salicylamide on skeletal glycosaminoglycan sulfation and calcification in fetal rat limbs. Drug Nutr Interact. 1981;1 (1) :75-86.|[3]Knight E, et al. Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat. J Nutr. 1978 Feb;108 (2) :216-25.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Scientific Category:

  Natural Products

• Clinical Information:

  Launched

• CAS Number:

  [65-45-2]